ENTITY

CSL (CSL AT)

2
Analysis
Health Care • United States
CSL Limited develops, manufactures, and markets human pharmaceutical and diagnostic products derived from human plasma. The Company provides products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
•01 Jun 2026 10:26

MS-Australia Index Earning Revision (May): Evolution Mining, National Australia Bank, CSL, ANZ

We analyzed MS-Australia's consensus for May 2026 and highlighted changes of EPS in Evolution Mining, National Australia Bank, CSL, ANZ, Brambles,...

Logo
127 Views
Share
•06 Mar 2019 06:07

Aussie Equities Reporting Season Wrap: March 2019

Australia rallied strongly through a relatively solid reporting season, with the benchmark ASX 200 posting a strong 6% gain in the month. EPS was...

Logo
385 Views
Share
•20 Feb 2019 07:43

Aussie Reporting Season Update: February 2019

The Banks remain under earnings pressure from several fronts, with weak credit growth, falling net interest margins and rising compliance costs...

Logo
742 Views
Share
bullish•Terumo Corp
•26 May 2026 08:30

Terumo Corp (4543 JP): FY26 Revenue Hits Record High; Profitability Improvement to Continue

​Terumo exceeds FY26 revenue guidance and achieves record high operating profit. The company expects significant profit growth in FY27 and aims for...

Logo
151 Views
Share
•05 Dec 2018 06:37

Aussie Equities 2019: On a Wing and a Prayer

We expect 2019 will be challenging. Offshore macro and Geopolitical issues emerged in 2018 to dash our expectations of a good year for the Aussie...

Logo
661 Views
Share
x